Target intelligence / Profile preview

CXXC4 antisense RNA 1 (CXXC4-AS1)

Target
CXXC4-AS1
Molecular classification
Other, long non-coding RNA, lncRNA
01

Overview

CXXC4 antisense RNA 1 (CXXC4-AS1) is a long non-coding RNA (lncRNA) gene in Homo sapiens. It is transcribed as an RNA molecule but is not believed to code for a protein[3][8][2]. The gene is named as an “antisense” transcript to the nearby CXXC4 gene, but its precise biological function and role in disease have not yet been clearly characterized or linked to a specific pathway or phenotype in current reference sources[8][10][3]. There are no data to support its use as a therapeutic target, nor are there known drugs, mechanisms, or biomarkers directly related to this molecule from current databases and literature[3][8][10]. Clarification: CXXC4-AS1 should not be confused with CXXC finger protein 4 (CXXC4 or Idax), a protein-coding gene with known tumor suppressor properties[1][7]. In the current literature and gene databases, CXXC4-AS1 is classified as a long non-coding RNA, with no established biological or disease role, drug interaction, or biomarker status. Thus, it is not considered a classical molecular target (such as a receptor, enzyme, etc.) for therapeutic intervention[3][8].

Other names
CXXC4-AS1
02

Biological functions

Unknown (not clearly defined in current literature; as a long non-coding RNA, may be involved in gene regulation)
03

Disease associations

Unknown (no direct implication clearly established in current search results)

Beyond the preview

Go deeper on CXXC4 antisense RNA 1 (CXXC4-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on CXXC4 antisense RNA 1 (CXXC4-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call